98
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Non-Persistence with Medication as a Mediator for the Social Inequality in Risk of Major Adverse Cardiovascular Events in Patients with Incident Acute Coronary Syndrome: A Nationwide Cohort Study

ORCID Icon, ORCID Icon, , , &
Pages 1071-1083 | Published online: 13 Nov 2021

References

  • Mensah GA, Wei GS, Sorlie PD, et al. Decline in cardiovascular mortality: possible causes and implications. Circ Res. 2017;120(2):366–380. doi:10.1161/CIRCRESAHA.116.30911528104770
  • Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356(23):2388–2398. doi:10.1056/NEJMsa05393517554120
  • Joensen AM, Joergensen T, Lundbye-Christensen S, et al. Explaining Trends in Coronary Heart Disease Mortality in Different Socioeconomic Groups in Denmark 1991–2007 Using the IMPACT SEC Model. PLoS One.2018;13(4):e0194793.29672537
  • Stirbu I, Looman C, Nijhof GJ, et al. Income inequalities in case death of ischaemic heart disease in the Netherlands: a national record-linked study. J Epidemiol Community Health. 2012;66(12):1159–1166. doi:10.1136/jech-2011-20092422685304
  • Schultz WM, Kelli HM, Lisko JC, et al. Socioeconomic status and cardiovascular outcomes. Circulation. 2018;137(20):2166–2178. doi:10.1161/CIRCULATIONAHA.117.02965229760227
  • Alter DA, Franklin B, Ko DT, et al. Socioeconomic status, functional recovery, and long-term mortality among patients surviving acute myocardial infarction. PLoS One. 2013;8(6):e65130. doi:10.1371/journal.pone.006513023755180
  • Rasmussen JN, Gislason GH, Rasmussen S, et al. Use of statins and beta-blockers after acute myocardial infarction according to income and education. J Epidemiol Community Health. 2007;61(12):1091–1097. doi:10.1136/jech.2006.05552518000133
  • Pedersen M, Egerod I, Overgaard D, et al. Social inequality in Phase II cardiac rehabilitation attendance: the impact of potential mediators. Eur J Cardiovasc Nurs. 2018;17(4):345–355. doi:10.1177/147451511774601129185799
  • Jakobsen L, Niemann T, Thorsgaard N, et al. Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention. Circ Cardiovasc Interv. 2012;5(5):641–648. doi:10.1161/CIRCINTERVENTIONS.112.96827123031837
  • Dalen M, Ivert T, Holzmann MJ, et al. Household disposable income and long-term survival after cardiac surgery. J Am Coll Cardiol. 2015;66(17):1888–1897. doi:10.1016/j.jacc.2015.08.03626493661
  • Nielsen S, Karlsson M, Björklund E, et al. Socioeconomic factors, secondary preventive medication, and long-term Survival after coronary artery bypass grafting: a population-based cohort study from the SWEDEHEART registry. J Am Heart Assoc. 2020;9(5):e015491. doi:10.1161/JAHA.119.01549132114890
  • Hagen TP, Häkkinen U, Iversen T, et al. Socio-economic inequality in the use of procedures and mortality among AMI patients: quantifying the effects along different paths. Health Econ. 2015;24:102–115. doi:10.1002/hec.326926633871
  • Mårtensson S, Gyrd-Hansen D, Prescott E, et al. Socio-economic position and time trends in invasive management and case fatality after acute myocardial infarction in Denmark. Eur J Public Health. 2016;26(1):146–152. doi:10.1093/eurpub/ckv15626342131
  • Collet J, Thiele H, Germany C, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020;5:1–79.
  • Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39:119–177.28886621
  • Khandelwal A, Bakir M, Bezaire M, et al. Managing Ischemic heart disease in women: role of a women’s heart center. Curr Atheroscler Rep. 2021;23(10). doi:10.1007/s11883-021-00956-x
  • Ohm J, Skoglund PH, Discacciati A, et al. Socioeconomic status predicts second cardiovascular event in 29,226 survivors of a first myocardial infarction. Eur J Prev Cardiol. 2018;25(9):985–993. doi:10.1177/204748731876664629664673
  • Bernheim SM, Spertus JA, Reid KJ, et al. Socioeconomic disparities in outcomes after acute myocardial infarction. Am Heart J. 2007;153:313–319.17239695
  • Kelli HM, Mehta A, Tahhan AS, et al. Low educational attainment is a predictor of adverse outcomes in patients with coronary artery disease. J Am Heart Assoc. 2019;8(17):e013165. doi:10.1161/JAHA.119.01316531476920
  • Danish Medicines Agency. Reimbursement thresholds. https://laegemiddelstyrelsen.dk/en/reimbursement/calculate-reimbursement/reimbursement-thresholds/
  • Jensen VM, Rasmussena AW. Danish education registers. Scand J Public Health. 2011;39(7_suppl):91–94. doi:10.1177/140349481039471521775362
  • Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39(7_suppl):103–105. doi:10.1177/140349481140509821775365
  • Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x22486599
  • De GS, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med. 2018;169(1):30–35. doi:10.7326/M18-054329946690
  • Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7_suppl):38–41. doi:10.1177/140349481039471721775349
  • Schmidt M, Pedersen L, Sørensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-324965263
  • Fewell Z, Hernan MA, Wolfe F, et al. Controlling for time-dependent confounding using marginal structural models. Stata J. 2004;4(4):402–420. doi:10.1177/1536867X0400400403
  • Lange T, Hansen KW, Sørensen R, et al. Applied mediation analyses: a review and tutorial. Epidemiol Health. 2017;39:e2017035. doi:10.4178/epih.e201703529121709
  • Rasmussen JN, Rasmussen S, Gislason GH, et al. Mortality after acute myocardial infarction according to income and education. J Epidemiol Community Health. 2006;60(4):351–356. doi:10.1136/jech.200X.04097216537354
  • Shimony A, Zahger D, Ilia R, et al. Impact of the community ’ s socioeconomic status on characteristics and outcomes of patients undergoing percutaneous coronary intervention. Int J Cardiol. 2010;144(3):379–382. doi:10.1016/j.ijcard.2009.04.03319446896
  • Biswas S, Andrianopoulos N, Duffy SJ, et al. Impact of socioeconomic status on clinical outcomes in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 2019;12(1):e004979. doi:10.1161/CIRCOUTCOMES.118.00497930606051
  • King W, Lacey A, White J, et al. Socioeconomic inequality in medication persistence in primary and secondary prevention of coronary heart disease – a population-wide electronic cohort study. PLoS One. 2018;13(3):1–12. doi:10.1371/journal.pone.0194081
  • Avlund K, Holstein BE, Osler M, et al. Social position and health in old age: the relevance of different indicators of social position. Scand J Public Health. 2003;31(2):126–136. doi:10.1080/1403494021013413012745763
  • Gislason GH, Rasmussen JN, Abildstrøm SZ, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006;27(10):1153–1158. doi:10.1093/eurheartj/ehi70516399775
  • Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. J Am Med Assoc. 2007;297(2):177–186. doi:10.1001/jama.297.2.177
  • Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940–2948. doi:10.1093/eurheartj/eht29523907142
  • Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378:1231–1243.21872920
  • Mann DM, Woodward M, Muntner P, et al. Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother. 2010;44(9):1410–1421. doi:10.1345/aph.1P15020702755
  • Barrett E, Paige E, Welsh J, et al. Differences between men and women in the use of preventive medications following a major cardiovascular event: Australian prospective cohort study. Prev Med Reports. 2021;22:101342. doi:10.1016/j.pmedr.2021.101342
  • Andersen J, Gerds TA, Hlatky MA, et al. The mediating role of effective treatments in the relationship between income level and survival in patients with heart failure: a sex- and cohabitation-stratified study. Eur J Prev Cardiol. 2021;28:78–86.33623976
  • Galobardes B, Shaw M, Lawlor DA, et al. Indicators of socioeconomic position (part 1). J Epidemiol Community Health. 2006;60(1):7–12. doi:10.1136/jech.2004.023531
  • Sciomer S, Moscucci F, Maffei S, et al. Prevention of cardiovascular risk factors in women: the lifestyle paradox and stereotypes we need to defeat. Eur J Prev Cardiol. 2019;26(6):609–610. doi:10.1177/204748731881056030373379
  • Schmidt M, Schmidt SAJ, Sandegaard JL, et al. The Danish National patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S9112526604824
  • Carter AR, Gill D, Davies NM, et al. Understanding the consequences of education inequality on cardiovascular disease: Mendelian randomisation study. BMJ. 2019;365:1–12.
  • Nordahl H, Rod NH, Frederiksen BL, et al. Education and risk of coronary heart disease: assessment of mediation by behavioral risk factors using the additive hazards model. Eur J Epidemiol. 2013;28(2):149–157. doi:10.1007/s10654-012-9745-z23179630